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Liposomes derivatized with tetrabranched neurotensin
peptides via click chemistry reactions†
Antonella Accardo, Paola Ringhieri, Diego Tesauro and Giancarlo Morelli*
Liposomes decorated with neurotensin tetramers are obtained by using a post-liposomal derivatization
method in which a click-chemistry reaction between liposomes containing azido functions on the external
surface, DOPC/(C18)2-Peg9-N3 (90/10), and branched neurotensin peptides modified for the presence of
a CRC triple-bond [(NT8-13)4-alkyne] is performed. Results show that the post liposomal derivatization
method is very eﬃcient and that click-chemistry procedures are very attractive for nanoparticle
functionalization. A structural characterization of liposomes has been performed by dynamic light
scattering (DLS) measurements. The hydrodynamic radii of pure DOPC and mixed DOPC/(C18)2-Peg9-N3
and DOPC/(C18)2-Peg-triazole-(NT8-13)4 liposomes (at 90 : 10 molar ratio) are 61  21 nm, 60  22 nm
and 82  43 nm, respectively. A very eﬃcient doxorubicin loading has been observed, specially for DOPC/
(C18)2-Peg9-N3 liposomes, with a drug loading content of 90%.
Introduction
Nowadays, nanoscopic (10–500 nm) systems such as polymeric
micelles, dendrimers, liposomes and inorganic nanoparticles
that incorporate therapeutic agents, diagnostic probes and
molecules for selective targeting are emerging as the next
generation of multifunctional nanomedicines for improving the
therapeutic outcome of drug therapy.1 The motivations for the
widespread application of nanomedicine depend on the potential
advantages of nanosystems with respect to conventional small
molecule-based therapy: high payload capacity, reduced toxicity to
healthy tissue, and improved antitumor efficacy.2 Moreover,
nanosystems can selectively extravasate into tumor tissue more
rapidly than drugs at low molecular weight and can remain in
circulation for an extended period of time when injected
intravenously.3,4 This phenomenon, identified as ‘‘enhanced
permeability and retention (EPR) effect’’,5 represents a form of
selective delivery termed ‘passive targeting’. More recently,
several authors have highlighted the importance of using
targeted liposomes functionalized with bioactive peptides to
realize an active targeting to the cancerous organs.6–12 Many
synthetic strategies have been established by modifying liposome
surfaces with targeting peptide sequences.13 The obvious goal
of each approach is to achieve high coupling efficiency, leaving
the bioactive peptide far away from the liposome surface and in
its right specific conformation ready for binding to the target. The
main difference between the different approaches concerns the
introduction of the bioactive peptide on the liposome surface:
the peptide should be introduced directly during liposome
formulation by using a peptide amphiphile, or after liposome
preparation by modifying the liposome surface. Peptide coupling
after liposome preparation involves the introduction of suitable
activated functional groups into the external side of the liposomes
for covalent or non-covalent binding of the peptide. Functional
groups commonly used are: (a) amines for the amine-N-hydroxy-
succinamide couplingmethod, (b) maleimide forMichael addition,
(c) azides for Cu(I)-catalyzed Huisgen cycloaddition (CuAAC), (d)
biotin for non-covalent interaction with avidin or triphosphines
for Staudinger ligation.13 The synthetic strategy to adopt should
be opportunely selected in order to increase the reproducibility
and the yield of the coupling reaction.
We previously reported the structural characterization and
the in vitro behaviour of DOPC liposomes containing the cytotoxic
drug Doxorubicin (Doxo) functionalized on the external surface
with linear or tetrabranched form of truncated neurotensin peptide
NT(8-13).14,15 This C-terminal NT peptide fragment is well known
for its ability to mimic the NT peptide in receptor binding.16,17
Target liposomes were prepared by mixing together commercial
DOPC phospholipids and synthetic (C18)2-L(NT8-13) or
(C18)2Lys(NT8-13)4 peptide amphiphiles (PAs). The selective
internalization of NT-derivatized liposomes, compared to nude
liposomes, was tested in HT29 human colon adenocarcinoma
and TE671 human rhabdomyosarcoma by confocal microscopy.
Cytotoxicity of NT4-liposomal doxorubicin increased four-fold
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with respect to untargeted DOPC-Doxo liposomes in both cell
lines. Results from fluorescence-activated cell sorting (FACS)
analysis are in line with these results, resulting in a fluores-
cence signal increase of the NT4 liposomes as compared to the
nude analogues. Moreover, liposomes decorated with the
branched peptide showed a better profile in drug delivery, with
respect to liposomes decorated with the corresponding mono-
meric peptide.
This achievement might be seen as a general approach to
increase the exposure of carriers on the surface of the nano-
particles, which is a frequently wanted matter. The use of
multimeric peptides as decorating units of nanoparticles has,
eventually, the advantage of increasing the amount of hydro-
philic carrier to be exposed to target cells. Recently, peptide
tetramerization approach for liposome delivery has been
successfully applied also for peptides selected by phage display
(avb6-specific H2009.1 peptide).18 Besides, the presentation of
peptides in a grouped shape facilitates binding and fusion of
nanoparticles to cells.
Here, we describe the preparation of liposomes decorated
with NT tetramers obtained by using a click-chemistry reaction
between liposomes containing azido functions on the external
surface and branched neurotensin peptides modified for
the presence of a CRC triple-bond [(NT8-13)4-alkyne].
19,20
Structural characterization and drug loading capability of targeted
liposomes are also reported.
Results and discussion
Design and synthesis of liposomes decorated with branched
NT8-13
Surface functionalization of supramolecular aggregates such as
liposomes and micelles with bioactive peptides can be achieved
introducing peptide amphiphiles (PAs) directly during the
formulation, in the lipid film preparation step. PAs can be
synthesized in solid phase by coupling one or more alkyl chains
to a functional group of the peptide. Nevertheless, the solid
phase peptide synthesis (SPPS) approach works well only for
short and hydrophilic peptide sequences. More complexes and
hydrophobic sequences, in which the low solubility of the
peptide is combined with the high hydrophobicity of the alkyl
chains, require the development of alternative methodologies
for synthesis, purification and collection of pure compounds.21
Moreover, when a dimeric or a tetrameric form of the peptide is
required to increase its biological activity (i.e. neurotensin), the
final yield of the purified amphiphilic product could signifi-
cantly decrease. In these cases, PAs should be synthesized by
using a divergent approach or by combining solid phase and
solution approaches. As alternative to the PA preparation,
diﬀerent strategies for liposomes or micelles bioconjugation
can be exploited.13,22 Peptide coupling can be performed after
liposomes assembly by using activated functional groups intro-
duced into the external side of the liposomes, according to
a post-liposomal derivatization method. Functional groups
should remain available on the surface for an eﬃcient chemical
ligation of the peptide. The application of click chemistry is
particularly appealing because of its regiospecificity, chemo-
selectivity, and tolerance to a wide variety of other functional
groups. The external surface of preformed DOPC liposomes
containing 10mol% of the (C18)2-Peg9-N3 azido-derivative could be
modified with four copies of the NT8-13 peptide [(NT8-13)4] by
using click reaction in aqueous solution with stoichiometric
amounts of tetrameric peptide (NT8-13)4 bearing a propargylglycine
moiety [(NT8-13)4-alkyne].
Both the reactants used in the click-chemistry process [(NT8-13)4-
alkyne and (C18)2-Peg9-N3], schematized in Fig. 1, were synthesized
by SPPS with Fmoc/tBu chemistry according to standard protocols.
Chemical synthesis of (C18)2-Peg9-N3 was performed on rink
amide resin, according to Scheme 1. As previously reported for
other amphiphilic azido-derivatives, no reductive side reactions
were observed during the cleavage step of the product from the
resin.23 (NT8-13)4-alkyne was synthesized on Novasyn TGR
resin with a low functionalization degree. Low density of
anchorage functional groups is suitable to avoid interactions
Fig. 1 Schematic representation of (C18)2-Peg9-N3 and (NT8-13)4-alkyne.
Scheme 1 Scheme for the solid-phase synthesis of the (C18)2-Peg9-N3 monomer.
The rink-amide resin is schematically represented as an empty circle.
Paper NJC
3530 New J. Chem., 2013, 37, 3528--3534 This journal is c The Royal Society of Chemistry and the Centre National de la Recherche Scientifique 2013
between the growing peptide chains thus increasing synthetic
yields. Four copies of NT8-13 peptide were assembled, step by
step, on a core matrix of a branched lysine scaﬀold. The core
matrix also contains the alkyne functional group for the presence
of a propargylglycine residue introduced between the solid
support and the lysine residue. The high soluble crude product
was easily purified by RP-HPLC chromatography and obtained
in good yields (Fig. 2). Hence, both reactants were collected in
good yields (85% and 50%, respectively) after HPLC-RP purifica-
tion, and analyzed by mass spectrometry (MS-ESI), 1H and 13C
NMR spectroscopy (for (C18)2-Peg9-N3), and HPLC to confirm
compound identities and their purity.
Liposome formulation and characterization
Mixed DOPC/(C18)2-Peg9-N3 (90/10) liposomes were obtained
according to standard procedures14 in which a lipid film of the
two monomers in the chosen ratio was hydrated by addition of
10 mMHEPES buﬀer at pH 7.4, sonicated, and extruded through
a polycarbonate membrane with 100 nm pore size. The number
of functional groups present on the liposomal surface was checked
by using 7-nitrobenzofurazan (NBD)-labeled Pra fluorescent
derivative as previously described.21 Results confirm that about
50% of the azido functions are present on the external surface
of the liposome. The bioconjugation reaction was carried out
after liposome formulation. This strategy allows us to have the
bulky peptide derivative only on the liposome external surface,
leaving the liposome inner compartment empty, thus available
to load a large amount of Doxorubicin. Click chemistry reaction
was carried out on DOPC/(C18)2-Peg9-N3 liposomes at 1  103 M
concentration in 10 mM HEPES buﬀer, by adding CuSO45H2O,
ascorbic acid, and the peptide derivative 1 equivalent of (NT8-13)4-
alkyne with respect to the azido moiety, as schematized in Fig. 3.
After click chemistry reaction, liposomes were separated from
free alkyne-peptides and from copper ions by gel-filtration and
the conjugation eﬃciency was calculated by the RP-HPLC
calibration curve as the ratio of unbound (NT8-13)4-alkyne to
its total amount. The results confirm that the yield of the
reaction was higher than 95% after 12 h at room temperature.
The liposomal fraction was then treated with a Triton solution
10 and (C18)2-Peg9-triazole-(NT8-13)4 was isolated and char-
acterized by LC-MS and UV-Vis spectroscopy (Fig. 4). The
product isolated at 17.15 minutes in a preparative HPLC course
corresponds the product of the click reaction, with a typical
UV/Vis spectrum in which there are three absorbance peaks: the
peak at 210 nm relative to the amide bond, the peak at 267 nm
due to four tyrosine residues present in the tetrabranched
Fig. 2 Analytical characterization by LC-MS of (NT8-13)4-alkyne. (A) HPLC pro-
file; (B) MS spectrum showing peaks at 1279.1 ([M + 3H+]/3), 959.7 ([M + 4H+]/4)
and 767.9 ([M + 5H+]/5) and their corresponding satellite peaks, representing the
[M + H+ + 2K+]/3, the [M + 2H+ + 2K+]/4 and the [M + 3H+ + 2K+]/5, respectively.
Fig. 3 Coupling of the (NT8-13)4-alkyne tetramer to the azide-functionalized
liposomes by a click-chemistry reaction.
Fig. 4 (A) Schematic representation of (C18)2-Peg9-triazole-(NT8-13)4 and (B)
its HPLC profile and the UV/Vis spectrum.
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neurotensin, and the peak at 350 nm of the triazole ring. Finally,
the mass spectrum confirms the identity of the product.
The size of pure DOPC liposomes, mixed DOPC/(C18)2-Peg9-
N3 (90/10) and DOPC/(C18)2-Peg9-triazole-(NT8-13)4 (90/10)
liposomes, i.e. before and after click-chemistry reaction, was
assessed by dynamic light scattering (DLS). Measurements were
performed at y = 1731 on liposomes at 2  104 M concen-
tration in 10 mMHEPES buﬀer at pH 7.4. Hydrodynamic radius
(RH) distribution functions of liposomes are reported in Fig. 5
and RH, diﬀusion coeﬃcients and polydispersity index (P.I.) of
all systems are summarized in Table 1. Inspection of Fig. 5
shows that all liposome solutions present a monomodal dis-
tribution due to a translational diﬀusion process, which could
be attributed to liposome aggregates. The hydrodynamic radii
of pure DOPC and mixed DOPC/(C18)2-Peg9-N3 and DOPC/
(C18)2-Peg-triazole-(NT8-13)4 liposomes (at 90 : 10 molar ratio)
are 61  21 nm, 60  22 nm and 82  43 nm, respectively.
As expected, the size of mixed DOPC/(C18)2-Peg9-N3 liposomes
is quite similar to the size of pure DOPC liposomes, thus
confirming that the introduction of a small amount of the
synthetic monomer does not influence the size of the
DOPC liposomes.22 After click chemistry reaction, a structural
evolution of liposomes occurs (see Fig. 5) and an increase of
diameter from 60.0 nm to 82.1 nm was observed for DOPC/
(C18)2-Peg-triazole-(NT8-13)4 liposomes, as expected for the
presence of the tetrameric NT peptides well exposed on the
outer liposome surface (Table 1).
Doxorubicin encapsulation
The cytotoxic drug doxorubicin (Doxo) was loaded into pure
DOPC liposomes and into mixed liposomes before (DOPC/
(C18)2-Peg9-N3) and after (DOPC/(C18)2-Peg-triazole-(NT8-13)4)
their functionalization by click-chemistry reaction. In all systems,
drug encapsulation was performed using the ammonium gradi-
ent method24 and an initial drug(wt)/lipid(wt) ratio of 0.100. The
Doxo loading content values (DLC), reported in Table 2, were
calculated by fluorescence measurements with subtraction of the
amount of free doxorubicin, eluted by gel filtration, from the
total amount of initial doxorubicin. The Doxo loading contents
(DLC) defined as the weight ratio of the encapsulated Doxo
versus the amount of the amphiphilic molecules forming
liposomes were 0.095 for pure DOPC liposomes and 0.090 for
mixed DOPC/(C18)2-Peg9-N3 liposomes corresponding to 95%
and 90%, respectively, of the used doxorubicin. Only a slight
decrease of DLC is found when (C18)2-Peg9-N3 is co-assembled
with DOPC forming liposomes. In contrast, DOPC/(C18)2-Peg-
triazole-(NT8-13)4 liposomes, in which the outer liposomal
surface is partially hindered by four copies of the neurotensin
peptides, show a lower DLC value of 0.078 (78% of the
used Doxo).
This value is higher with respect to that found for DOPC/
(C18)2Lys(NT8-13)4 liposomes (DLC of 0.065 corresponding to
65% of the used Doxo) prepared by using (C18)2Lys(NT8-13)4
peptide amphiphile directly during the formulation step.15 In
fact, in the latter case, both inner and outer liposome surfaces
Fig. 5 DLS spectra of DOPC/(C18)2-Peg9-N3 (90/10) at 25 1C before and after
the functionalization by click-chemistry reaction. DLS spectrum of pure DOPC
liposomes is also reported for comparison.
Table 1 Structural parameters (hydrodynamic radii, diﬀusion coeﬃcients and polydispersity indexes) obtained from dynamic light scattering measurements for the
studied systems
Systems RH/nm D  1012 m2 s1 P.I.  S.D.
DOPC 62  21 3.3  1.1 0.079  0.002
DOPC/(C18)2-Peg9-N3 60  22 3.3  1.2 0.095  0.005
DOPC/(C18)2-Peg9-triazole-(NT8-13)4 82  43 2.4  1.2 0.240  0.015
Table 2 Drug loading content (DLC, defined as the ratio between weight of
encapsulated Doxo and the total weight of amphiphilic molecules forming
liposomes), for the diﬀerent formulations. In all experiments an initial drug(wt)/
lipid(wt) ratio of 0.100 was used
Systems DLC
DOPC 0.095
DOPC/(C18)2-Peg9-N3 0.090
DOPC/(C18)2-Peg9-triazole-(NT8-13)4 0.078
DOPC/(C18)2Lys(NT8-13)4 0.065
a
a Value from ref. 15.
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are obstructed by NT tetramers, thus comporting a space
decrease of the inner liposomal compartment. The above
reported data suggest that a very eﬃcient loading procedure
to obtain Doxo liposomes covered by tetrameric NT peptides
could be based on a two-step process: in a first step doxorubicin
should be loaded in DOPC/(C18)2-Peg9-N3 liposomes (90% of
loading eﬃciency), and, then, in a second step Doxo loaded
liposomes could be derivatized by click chemistry reaction with
tetrameric NT peptides.
Conclusions
Liposomes decorated with bioactive peptides can be prepared
by using several synthetic approaches: an approach consists of
the self-assembling process of phospholipids with peptide
amphiphiles (PAs), whereas the other method needs a post-
modification of the liposomes, introducing the bioactive peptides
on the external liposome surface. In first approximation, for basic
studies, both approaches are always possible, but when the final
objective is the preparation of a new liposomal drug for clinical
studies or for the market, the scaling up process should be taken
into consideration. In these cases the choice of one procedure
with respect to the other one is a critical decision and it depends
on a preventive study of the properties of the peptide sequence
(length and hydrophobicity). When the peptide required for
binding is represented by poorly soluble sequences or by branched
peptide forms, the post-liposomal derivatization method should be
preferred. By using the post-liposomal derivatization method two
diﬀerent compounds should be synthetically prepared: an amphi-
philic compound modified on its hydrophilic head with a reactive
moiety, and a peptide derivative containing the other reactant
function on its N- or C- terminal end. The synthesis of two diﬀerent
molecules could be more eﬃcient, in terms of yield and final
purity, with respect to the synthesis of a single, but very complex,
amphiphilic molecule containing both a bioactive peptide and the
hydrophobic moiety based on hydrocarbon chains. This is espe-
cially true when high amounts are requested. We have described
the preparation of liposomes decorated with neurotensin tetramers
obtained by using the post-liposomal derivatization method based
on a click-chemistry reaction between liposomes containing azido
groups on the external surface and branched neurotensin peptides
derivatized with an alkyne function [(NT8-13)4-alkyne]. Using
this procedure we have obtained DOPC/(C18)2-Peg9-triazole-
(NT8-13)4 liposomes, very similar to the already published
DOPC/(C18)2Lys(NT8-13)4 liposomes that showed to be very eﬃcient
target selective drug delivery systems for tumour cells expressing
neurotensin receptors,15 with the additional advantage of a higher
doxorubicin loading content with respect to the previous system.
Results show that for branched peptides, also if short
peptide sequences are employed, as for the truncated NT
form (NT8-13), the post liposomal derivatization method is
very eﬃcient. Moreover, the obtained data indicate that click-
chemistry based reactions are very attractive procedures to be
employed in nanoparticle functionalization. Finally, the post-
liposomal derivatization method allows us to obtain liposomes
in which bioactive peptides are present only on the external
surface, leaving more space in the liposome inner compart-
ment thus allowing a very high drug loading content.
Experimental
Materials and instrumentation
Fmoc-protected amino acid derivatives, coupling reagents, and
resins (rink amide p-methylbenzhydrylamine MBHA and NovaSyns
TGR) were purchased from Calbiochem–Novabiochem (Laufel-
fingen, Switzerland). Fmoc-L-propargylglycine (Fmoc-Pra-OH)
was purchased from Neosystem (Strasbourg, France). The
14-azido-5-oxo-3,9,12-trioxa-6-azatetradecan-1-oic acid (N3-Peg(9)-
COOH) was purchased by Iris Biotech GmbH (Marktredwitz,
Germany). (8S,10S)-10-(4-amino-5-hydroxy-6-methyl-tetrahydro-2H-
pyran-2-yloxy)-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-
7,8,9,10-tetra hydro-tetracene-5,12-dione; (doxorubicin HCl)
was purchased from Sigma-Aldrich. 1,2-Dioleoyl-sn–glycero-3-
phosphocholine (DOPC) was purchased from Avanti Polar
Lipids (Alabaster, AL, USA). N,N-Dioctadecylsuccinamic acid
was synthesized according to a published procedure.25 All other
chemicals were commercially available by Sigma-Aldrich, Fluka
(Buchs, Switzerland), or LabScan (Stillorgan, Dublin, Ireland)
and were used as received, unless otherwise stated. Preparative
HPLC was carried out on a LC8 Shimadzu HPLC system (Shimadzu
Corporation, Kyoto, Japan) equipped with a UV lambda-Max
Model 481 detector using a Phenomenex (Torrance, CA) C18
(300 Å, 250 21.20 mm, 5 m) column eluted with H2O/0.1% TFA
(A) and CH3CN/0.1% TFA (B) from 5–70% over 15 min at a flow
rate of 20 mL min1. Purity and identity were assessed by
analytical LC-MS analyses by using Finnigan Surveyor MSQ
single quadrupole electrospray ionization (Finnigan/Thermo
Electron Corporation San Jose, CA), column: C18-Phenomenex
eluted with H2O/0.1% TFA (A) and CH3CN/0.1% TFA (B) from
5–70% over 30 min at a flow rate of 0.8 mL min1. UV measure-
ments were performed on a UV/vis Jasco V-5505 spectrophoto-
meter equipped with a Jasco ETC-505T Peltier temperature
controller with a 1 cm quartz cuvette (Hellma). Fluorescence
spectra were recorded at room temperature on a Jasco Model
FP-750 spectrofluorophotometer in a 1.0 cm path length quartz cell.
Equal excitation and emission bandwidths were used throughout
the experiments, with a recording speed of 125 nm min1 and
automatic selection of the time constant. The liposomes were
extruded using amini-extruder purchased from Avanti Polar Lipids.
1H NMR and 13C NMR spectra were recorded on a Varian 400 MHz
spectrometer (Palo Alto, CA).
Synthesis of azide-Peg9-Lys(C(O)CH2CH2C(O)N
(C18H37)2)-amide (C18)2-Peg9-N3. The (C18)2-Peg9-N3 mono-
mer was synthesized in the solid phase under standard condi-
tions by using the Fmoc/tBu strategy. Rink-amide MBHA resin
(0.51 mmol g1, 0.1 mmol, 0.196 g) was used as a polymeric
support. The Fmoc protecting group on the resin was removed
by a DMF–piperidine (70 : 30) mixture. Fmoc-Lys(Mtt)-OH
(0.125 g, 0.2 mmol) was activated with PyBop (1 equiv.) and
HOBt (1 equiv.) and DIPEA (2 equiv.) in DMF and coupled to the
resin, while stirring the suspension for 1 h. The solution was
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filtered and the resin was washed four times with DCM; the Mtt
protecting group on the Ne-amino function of lysine was
removed by treatment with DCM–TIS–TFA (94 :5 :1, 5.0 mL) for
2 min. This procedure was repeated several times until the solution
became colorless. The resin was washed three times with DCM and
three times with DMF. Then, N,N-dioctadecylsuccinamic acid
(0.249 g, 0.4 mmol) was coupled according to the previously
published procedure.26 Successively, after Fmoc removal,
N3-Peg(9)-COOH (2 equiv.) was coupled under standard conditions
in DMF for 1 h to the Na terminus of the lysine residue. The product
was removed from the resin by treatment with TFA containing TIS
(2.5%), dithiothreitol (DTT, 2.5%), and water (2.5%) under vortexing
for 2 h. The crude product was slowly precipitated at 0 1C by adding
water drop-wise. The precipitate was washed several time with small
portions of water and lyophilized in order to remove the solvent. The
white solid was recrystallized from MeOH/H2O and recovered with
high yields (>85%). The product was identified by MS (ESI+) and
NMR spectroscopy.
(C18)2-Peg9-N3.
1H NMR (400 MHz, CDCl3/CD3OD 50 : 50):
d = 4.1 (m, 4H; OCH2CONH, OCH2CONH), 3.9 (m, 1H; CH
Lysa), 3.70 (s, 28H; OCH2CH2O), 3.4 (m 2H; N3CH2CH2O,),
3.25–3.20 (m, 8H; N–CH2 NHCH2CH2O), 3.20 (m, 2H; CH2Lyse,
2H; N3CH2CH2O), 2.64–2.49 (m, 4H; NHCOCH2CH2CO), 1.74
(m, 2H; CH2Lysb), 1.55 (m, 2H; CH2Lysd), 1.45 (m, 2H; CH2Lys4),
1.40 (m, 4H; RCH2CH3), 1.25 (m, 60H; CH2 aliphatic), 0.88 ppm
(t, 6H; CH3);
13C NMR (100.512 MHz, CDCl3/CD3OD 50 : 50): d = 173.98
(CONH2), 173.27 (CONH), 171.94 (CH3(CH2)17NCO), 170.55
(CONH), 72.0 (COCH2O), 71.0 (CH2N3), 70.4 (OCH2CH2O), 52.4
(NH(CH2)4CH), 51.0 (NHCH2(CH2)3CH), 48.6 (CH3(CH2)16CH2N),
46.8 (CH3(CH2)15CH2CH2N), 39.3 (NH(CH2)3CH2CH), 32.4–32.0
(NHCH2(CH2)2CH2CH), 29.2(NCOCH2CH2CONH), 30.2–27.5
(CH3CH2(CH2)14CH2CH2N), 23.17 (CH3CH2(CH2)16), 14.60 ppm
(CH3CH2(CH2)16)MS (ESI+): m/z (%) calcd for C68 H132N8O14
[M  H+]:1284.5; found: 1285.6 (100).
Synthesis of (NT8-13)4-alkyne
(NT8-13)4-alkyne was synthesized in the solid phase under
standard conditions by using the Fmoc/tBu strategy. Novasyn TGR
resin (0.24 mmol g1, 0.1 mmol, 0.420 g) was used as a polymeric
support. Fmoc-protected amino acids (4 equiv. relative to resin
loading) were coupled according to the PyBop/HOBt/DIPEAmethod:
Fmoc amino acid (1 equiv.), PyBOP (1 equiv.), HOBt (1 equiv.) and
DIPEA (2 equiv.) in DMF. The Fmoc protecting group was removed
with 30% piperidine in DMF (v/v). All couplings were performed
twice for 1 h. Fmoc-Pra-OH was coupled once for 45 min with
2 equivalents of PyBop/HOBt and 2 equivalents of DIPEA. At the end
of the core peptide synthesis, the four copies of NT8-13 peptide were
synthetized by adding amino acids step by step. The tetrabranched
peptide was fully deprotected and cleaved from the resin with TFA
containing triisopropylsilane (2.5%), and water (2.0%) as scavengers,
at room temperature for 2 h, and then precipitated with ice-cold
ethyl ether, filtered, dissolved in water, and lyophilized. The crude
alkyne derivative was purified by RP-HPLC. Purity and identity
were assessed by analytical LC-MS analyses. The final product
was obtained in 70% yield and analyzed by LC-MS: Rt = 12.68;
MS (ESI+): m/z (%) calcd [M  H+]: 3835; found: [M + 3H+]/3 =
1279.1; [M + 4H+]/4 = 959.7; [M + 5H+]/5 = 767.9
Liposome preparation and DLS characterization
All solutions were prepared by weight and buﬀered at pH 7.4 using
10 mM HEPES buﬀer. The pH was controlled using a pH meter
(MeterLab PHM220). Mixed aggregates of DOPC/(C18)2-Peg9-N3 (at
90 :10 molar ratio) were prepared as previously reported.14 Briefly,
the two amphiphiles were dissolved in a small amount of MeOH/
CHCl3 (50 :50); subsequently a thin film of amphiphiles was
obtained by evaporating the solvent by slowly rotating the tube
containing the solution under a stream of nitrogen. Lipid film was
hydrated by addition of 10mMHEPES buﬀer (pH 7.4), sonicated for
30 min and extruded 21 times through a polycarbonate membrane
(100 nm pore size) by using a mini-extruder purchased from Avanti
Polar Lipids (USA, Canada). After dilution of samples at 2.0  104
M concentration and centrifuged at room temperature at 13000 rpm
for 5min, hydrodynamic radii (RH) weremeasured by Dynamic light
scattering. DLS measurements were carried out using a Zetasizer
Nano ZS (Malvern Instruments, Westborough, MA) that employs a
1731 backscatter detector. Other instrumental settings are measure-
ment position (mm): 4.65; attenuator: 8; temperature 25 1C; cell:
disposable sizing cuvette. The number of azido functions present on
the outer surface of the liposomes was determined by using NBD-
labeled Pra. After click-chemistry reaction, the amount of NBD-Pra
bound to the liposome surface was estimated by fluorescence
spectroscopy by using the calibration curve obtained by measuring
the fluorescence emission at l = 530 nm.
Procedure for ‘‘Click’’ reaction
The Click reaction was carried out on DOPC/(C18)2-Peg9-N3 lipo-
somes at 1  103 M concentration in HEPES buﬀer. The reaction
was carried out by adding 4.4 equiv. of CuSO45H2O, 6.7 equiv. of
ascorbic acid, and 1 equiv. of the peptide derivative with respect to
the azido moiety. In particular, solutions containing CuSO45H2O
(40 mM, solution A), ascorbic acid (57 mM, solution B), and the
alkyne-modified peptide (1 mM, solution C) were freshly prepared
in water. Solution A (16.5 mL), solution B (17.5 mL), and solution
C (0.150 mL) were added to a suspension of azido-function-
alized liposomes in HEPES buﬀer (3.0 mL). The concentration of
solution Cwas determined bymeasuring the absorbance at 267 nm
(eTyr = 5400) on a UV/Vis Jasco V-5505 spectrophotometer. The
reaction mixture was stirred at 40 1C for 30 min and successively
left overnight at room temperature. After the conjugation step
the peptide-bound liposomes were separated from the unbound
peptide using Sephadex G-50 (Amersham Biosciences) column pre-
equilibrated with HEPES buﬀer. The number of (NT8-13)4 mole-
cules eﬀectively linked to the liposomal surface was determined
by using the RP-HPLC calibration curve. The percentage of func-
tionalization was calculated as the ratio of bound NT8-13 to their
total amount. The click-chemistry product, (C18)2-Peg9-triazole-
(NT8-13)4, was isolated by HPLC after treatment of the liposomal
fraction with Triton 10X (10 mL); it was then characterized by
RP-HPLC and UV-Vis spectroscopy. Rt: 17.15 min; MS (ESI+): m/z
(%) [M  H+]:5119; found: [M + 3H+]/3 = 1707.1; [M + 4H+]/4 =
1280.1; [M + 5H+]/5 = 1024.8.
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Doxorubicin loading
Doxorubicin was remote-loaded in pure DOPC, in mixed DOPC/
(C18)2-Peg9-N3 (90/10) liposomes, and in mixed DOPC/(C18)2-Peg9-
triazole-(NT8-13)4 (90/10) liposomes, by using the ammonium
sulfate gradient method.24 Briefly, a liposomal solution (1 mM)
was prepared as above reported in an ammonium sulfate solution
(250 mM) at pH 5.5. Liposomes were eluted on a Sephadex G-50
column pre-equilibrated with HEPES buﬀer (10 mM) at pH 7.4,
then 68 mL of doxorubicin from an aqueous stock solution (1.78 
103 M) were added to 1.0mL of liposomes in order to reach a drug
weight/lipid weight ratio of 0.100. The suspension was stirred for
30 min at 60 1C and subsequently unloaded Doxo was removed by
gel-filtration on a Sephadex column. The Doxo concentration in all
experiments was determined by UV-Vis spectroscopy using calibra-
tion curves obtained by measuring absorbance at l = 480 nm. The
drug loading content (DLC, defined as the weight ratio of encapsu-
lated Doxo versus the amphiphilic molecules forming liposomes)
was quantified by subtraction of the amount of removed Doxo from
the total amount of loaded Doxo.
Abbreviations
DIPEA N,N-Diisopropylethylamine
DLS Dynamic light scattering
DMF Dimethylformammide
DOPC Dipalmitoyl phosphatidyl glycerol
Doxo Doxorubicin
DTT Dithiothreitol
ESI-MS Electrospray ionization-mass spectrometry
FACS Fluorescence-activated cell sorting
Fmoc 9-Fluorenylmethoxycarbonyl
HOBt 1-Hydroxybenzotriazole
MBHA resin 4-Methylbenzhydrylamine resin
Mtt 4-Methyltrityl
Pip Piperidine
Pra Propargylglycine
PyBOP Benzotriazole-1-yl-oxytrispyrrolidinophospho-
nium hexafluoro phosphonate
RP-HPLC Reverse phase-high performance liquid
chromatography
SPPS Solid-phase-peptide-synthesis
TFA Trifluoracetic acid
TIS Triisopropylsilane
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